These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2469897)

  • 1. Age and pathophysiology-oriented antihypertensive response to calcium antagonists.
    Bühler FR
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S156-66. PubMed ID: 2469897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in the elderly: the role of calcium antagonists.
    Chalmers JP; Smith SA; Wing LM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S147-55. PubMed ID: 2469896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibition and calcium channel blockade as primary antihypertensive therapy.
    Bühler FR; Müller FB
    J Hypertens Suppl; 1986 Dec; 4(5):S435-40. PubMed ID: 3033183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular regulation as a function of age. Determinants of antihypertensive treatment based on beta-blockers and calcium inhibitors].
    Bühler FR
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():83-90. PubMed ID: 2868700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.
    Sowers JR; Mohanty PK
    Circulation; 1987 Jun; 75(6 Pt 2):V170-3. PubMed ID: 3552313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
    Bolli P; Erne P; Bühler FR
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and antihypertensive response to calcium antagonists.
    Bühler FR; Kiowski W
    J Hypertens Suppl; 1987 Dec; 5(4):S111-4. PubMed ID: 3326916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.